Literature DB >> 5472204

The inactivation of noradrenaline and isoprenaline in dogs.

R Gryglewski, J R Vane.   

Abstract

1. The removal of infused noradrenaline and isoprenaline from the circulation of the dog has been studied, using the blood-bathed organ technique.2. Both catecholamines were removed in peripheral vascular beds; in all organs studied, noradrenaline was removed to a greater degree than isoprenaline.3. The hind legs removed an average of 60% of the noradrenaline passing through, but only 34% of the isoprenaline. With noradrenaline, the degree of removal decreased as the concentration increased, but with isoprenaline, the degree of removal increased with concentration.4. After phenoxybenzamine, the proportion of isoprenaline removed was unchanged, whereas that of noradrenaline was decreased. The change in removal with the concentration of noradrenaline was also abolished.5. The results are consistent with the concept that a small fraction of infused noradrenaline is removed from the circulation by Uptake(1) and that this is blocked by phenoxybenzamine. Isoprenaline, and the rest of the noradrenaline, are removed by another process (Uptake(2)?) followed by intracellular metabolism. This inactivation process is unaffected by phenoxybenzamine in concentrations sufficient to give alpha-adrenoceptor blockade.6. After isoprenaline infusions, a substance sometimes appeared in the circulation which contracted the blood-bathed organs.7. The systemic pressure response to vaso-active hormones is not a reliable indicator of the concentration of hormone in the arterial circulation.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5472204      PMCID: PMC1702607          DOI: 10.1111/j.1476-5381.1970.tb10365.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Elimination of adrenaline and noradrenaline from the circulating blood.

Authors:  O CELANDER; S MELLANDER
Journal:  Nature       Date:  1955-11-19       Impact factor: 49.962

2.  The nature of hepatic and splenic sympathin.

Authors:  M MANN; G B WEST
Journal:  Br J Pharmacol Chemother       Date:  1950-06

Review 3.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

4.  Half-lives of peptides and amines in the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-09-16       Impact factor: 49.962

5.  Disappearance of catecholamines from the circulation.

Authors:  R Ginn; J R Vane
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

6.  Pulmonary extractionof bradykinin and eledoisin.

Authors:  P Biron
Journal:  Rev Can Biol       Date:  1968-03

7.  The estimation of catecholamines by biological assay.

Authors:  J R Vane
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

8.  Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.

Authors:  L L Iversen; S Z Langer
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

9.  Retention of injected catechol amines by the mouse.

Authors:  L L IVERSEN; L G WHITBY
Journal:  Br J Pharmacol Chemother       Date:  1962-10

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  13 in total

1.  Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat.

Authors:  G Eisenhofer; R McCarty; K Pacak; H Russ; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

2.  Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.

Authors:  N Himori; N Taira
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

3.  Lungs as a generator of prostacyclin--hypothesis on physiological significance.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz; J Spławiński; B Wojtaszek; J Swies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

4.  The effects of drugs and denervation on removal and accumulation of noradrenaline in the perfused hind-limb of the dog.

Authors:  W Osswald; D Branco
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Role of O-methylation in the renal excretion of catecholamines in dogs.

Authors:  K Hempel; H W Lange; E F Kayser; L Röger; H Hennemann; A Heidland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  The termination of action of catecholamines in the isolated venous tissue of the dog.

Authors:  W Osswald; S Guimarães; A Coimbra
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

7.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

8.  Measurement of regional neuronal removal of norepinephrine in man.

Authors:  D S Goldstein; R Zimlichman; R Stull; J Folio; P D Levinson; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

10.  Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres.

Authors:  Y L Lai; R C Mehta; A A Thacker; S D Yoo; P J McNamara; P P DeLuca
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.